Clinical Rheumatology

, Volume 33, Issue 9, pp 1347–1349

Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag


  • Phillip Scheinberg
    • Hematology Service, Oncology CenterHospital São José
  • Cristiane Carvalho Singulane
    • Rheumatology SectionFederal University of Mato Grosso
  • Luis Sergio Guedes Barbosa
    • Rheumatology SectionFederal University of Mato Grosso
    • Rheumatologist Hospital Israelita Albert Einstein
Case Based Review

DOI: 10.1007/s10067-014-2600-8

Cite this article as:
Scheinberg, P., Singulane, C.C., Barbosa, L.S.G. et al. Clin Rheumatol (2014) 33: 1347. doi:10.1007/s10067-014-2600-8


Eltrombopag is a new thrombomimetic medication approved for the treatment of immune thrombocytopenia. There are very few reports on the use of eltrombopag in patients with thrombocytopenia associated with sytemic lupus.We present a recent case of a patient with lupus with severe thrombocytopenia refractory to conventional therapy and full recovery with the use of eltrombopag. The present status of the literature with the use of this medication in patients with lupus is reviewed and discussed.



Copyright information

© Clinical Rheumatology 2014